{"id":61075,"date":"2023-12-04T11:08:45","date_gmt":"2023-12-04T02:08:45","guid":{"rendered":"https:\/\/monolith.law\/tr\/?p=61075"},"modified":"2024-03-17T17:13:58","modified_gmt":"2024-03-17T08:13:58","slug":"medical-advertising-charts","status":"publish","type":"post","link":"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts","title":{"rendered":"Avukat\u0131n A\u00e7\u0131klad\u0131\u011f\u0131 \u015eekilde T\u0131bbi Reklam K\u0131lavuzunun \u00d6nemli Noktalar\u0131"},"content":{"rendered":"\n<p>Hastane, klinik ve muayenehaneler gibi yerlerle ilgili reklam, bilgi sa\u011flama, kullan\u0131c\u0131 yorumlar\u0131 ve deneyim payla\u015f\u0131mlar\u0131 gibi i\u00e7eriklerin web \u00fczerinde yay\u0131nlanmas\u0131 durumunda, sorun olu\u015fturan konu, Japon Sa\u011fl\u0131k Hukuku ve Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131\u011f\u0131 Y\u00f6nergeleri&#8217;ne dayanan t\u0131bbi reklamc\u0131l\u0131kla ilgili yasal d\u00fczenlemelerdir.<\/p>\n\n\n\n<p>Bu t\u00fcr sa\u011fl\u0131kla ilgili reklamlar i\u00e7in, Japon Sa\u011fl\u0131k Hukuku ve Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131\u011f\u0131 Y\u00f6nergeleri&#8217;ne dayanan s\u0131k\u0131 reklam d\u00fczenlemeleri bulunmaktad\u0131r. Ayr\u0131ca, bu t\u00fcr reklam d\u00fczenlemeleri genellikle karma\u015f\u0131k ve anla\u015f\u0131lmas\u0131 zordur.<\/p>\n\n\n\n<p>\u00d6rne\u011fin, &#8220;deneyim payla\u015f\u0131m\u0131 reklamlar\u0131&#8221; yasakt\u0131r, ancak bir hastan\u0131n kendi iradesiyle, \u00f6rne\u011fin kendi blogunda,<\/p>\n\n\n\n<p>&#8220;\u25cf\u25cf Klini\u011fi&#8217;nde \u25cf\u25cf tedavisi g\u00f6rd\u00fcm ve \u00e7ok memnun kald\u0131m&#8221;<\/p>\n\n\n\n<p>gibi bir g\u00fcnl\u00fck yazmas\u0131 yasaklanmam\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p>\u0130nternet \u00fczerinde yay\u0131nlanabilecek ve &#8220;sonu\u00e7 olarak, belirli bir klini\u011fe belirli bir reklam etkisi sa\u011flayabilecek i\u00e7erikler&#8221; olduk\u00e7a geni\u015ftir.<\/p>\n\n\n\n<p>Japon Sa\u011fl\u0131k Hukuku ve Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131\u011f\u0131 Y\u00f6nergeleri&#8217;nin zor olmas\u0131n\u0131n bir nedeni, bu &#8220;geni\u015f kapsaml\u0131 durumlar&#8221;\u0131n her biri i\u00e7in, yasall\u0131\u011f\u0131n nas\u0131l de\u011ferlendirilmesi gerekti\u011fini anlama ihtiyac\u0131d\u0131r.<\/p>\n\n\n\n<p>Ancak, a\u015fa\u011f\u0131daki ak\u0131\u015f \u015femas\u0131n\u0131 kullanarak temel k\u0131s\u0131mlar\u0131 anlamak m\u00fcmk\u00fcn olacakt\u0131r.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_53 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Tibbi_Reklam_Kilavuzu_Akis_Semasi\" title=\"T\u0131bbi Reklam K\u0131lavuzu Ak\u0131\u015f \u015eemas\u0131\">T\u0131bbi Reklam K\u0131lavuzu Ak\u0131\u015f \u015eemas\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Dal_1_Tibbi_Reklamlarin_Uygunlugu\" title=\"Dal 1: T\u0131bbi Reklamlar\u0131n Uygunlu\u011fu\">Dal 1: T\u0131bbi Reklamlar\u0131n Uygunlu\u011fu<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Deneyim_Paylasimlari_ve_Tesvik_Edicilik_Degerlendirmesi\" title=\"Deneyim Payla\u015f\u0131mlar\u0131 ve Te\u015fvik Edicilik De\u011ferlendirmesi\">Deneyim Payla\u015f\u0131mlar\u0131 ve Te\u015fvik Edicilik De\u011ferlendirmesi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Genel_Gorusler_Ifade_Eden_Makaleler_ve_Belirlilik_Degerlendirmesi\" title=\"Genel G\u00f6r\u00fc\u015fler \u0130fade Eden Makaleler ve Belirlilik De\u011ferlendirmesi\">Genel G\u00f6r\u00fc\u015fler \u0130fade Eden Makaleler ve Belirlilik De\u011ferlendirmesi<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Tibbi_Hukukun_Uygulanmadigi_Durumlar_Ornek_1\" title=\"T\u0131bbi Hukukun Uygulanmad\u0131\u011f\u0131 Durumlar (\u00d6rnek 1)\">T\u0131bbi Hukukun Uygulanmad\u0131\u011f\u0131 Durumlar (\u00d6rnek 1)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Dal_2_Yasaklarin_Uygulanabilirligi\" title=\"Dal 2: Yasaklar\u0131n Uygulanabilirli\u011fi\">Dal 2: Yasaklar\u0131n Uygulanabilirli\u011fi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Dal_3_Sinirli_Kaldirma_Kosullarinin_Uygunlugu\" title=\"Dal 3: S\u0131n\u0131rl\u0131 Kald\u0131rma Ko\u015fullar\u0131n\u0131n Uygunlu\u011fu\">Dal 3: S\u0131n\u0131rl\u0131 Kald\u0131rma Ko\u015fullar\u0131n\u0131n Uygunlu\u011fu<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Sinirlamanin_Kaldirilma_Sartlarini_Karsiladigi_Durumlar_Model_2\" title=\"S\u0131n\u0131rlaman\u0131n Kald\u0131r\u0131lma \u015eartlar\u0131n\u0131 Kar\u015f\u0131lad\u0131\u011f\u0131 Durumlar (Model 2)\">S\u0131n\u0131rlaman\u0131n Kald\u0131r\u0131lma \u015eartlar\u0131n\u0131 Kar\u015f\u0131lad\u0131\u011f\u0131 Durumlar (Model 2)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Sinirlamanin_Kaldirilma_Sartlarini_Karsilamama_Durumu_Ornek_3\" title=\"S\u0131n\u0131rlaman\u0131n Kald\u0131r\u0131lma \u015eartlar\u0131n\u0131 Kar\u015f\u0131lamama Durumu (\u00d6rnek 3)\">S\u0131n\u0131rlaman\u0131n Kald\u0131r\u0131lma \u015eartlar\u0131n\u0131 Kar\u015f\u0131lamama Durumu (\u00d6rnek 3)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/monolith.law\/tr\/general-corporate\/medical-advertising-charts\/#Ozet\" title=\"\u00d6zet\">\u00d6zet<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tibbi_Reklam_Kilavuzu_Akis_Semasi\"><\/span>T\u0131bbi Reklam K\u0131lavuzu Ak\u0131\u015f \u015eemas\u0131<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Hadi hemen ak\u0131\u015f \u015femas\u0131na bir g\u00f6z atal\u0131m.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2021\/02\/fd9685467745bb70ad9d7058cb7b62cd-2.png\" alt=\"\" class=\"wp-image-29158\" \/><figcaption class=\"wp-element-caption\">T\u0131bbi Reklam K\u0131lavuzu Ak\u0131\u015f \u015eemas\u0131<\/figcaption><\/figure>\n\n\n\n<p>\u00dc\u00e7 farkl\u0131 noktada dallanmalar meydana gelmektedir ve her nokta hukuki yorumlar\u0131 i\u00e7erir. Hangi ifadelerin kullan\u0131labilece\u011fi bu yorumlara ba\u011fl\u0131 olarak de\u011fi\u015fir, bu y\u00fczden durum karma\u015f\u0131kt\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dal_1_Tibbi_Reklamlarin_Uygunlugu\"><\/span>Dal 1: T\u0131bbi Reklamlar\u0131n Uygunlu\u011fu<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>\u0130lk olarak, s\u00f6z konusu makalenin (veya makale i\u00e7indeki ifadelerin) ba\u015ftan ba\u015fa &#8216;t\u0131bbi reklam&#8217; kapsam\u0131na girip girmedi\u011fi sorulur.<\/p>\n\n\n\n<p>T\u0131bbi reklamlar\u0131n uygunlu\u011fu,<\/p>\n\n\n\n<ul>\n<li>Te\u015fvik Edicilik: Hastalar\u0131n muayeneye gitmelerini te\u015fvik eden bir niyetin olmas\u0131<\/li>\n\n\n\n<li>Belirlilik: T\u0131bbi hizmetler veya di\u015f hekimli\u011fi hizmetleri sunan ki\u015finin ad\u0131 veya unvan\u0131, hastane veya klini\u011fin ad\u0131n\u0131n belirlenebilir olmas\u0131<\/li>\n<\/ul>\n\n\n\n<p>olmak \u00fczere iki noktadan de\u011ferlendirilir. E\u011fer bu iki nokta da kabul edilirse, t\u0131bbi reklam kapsam\u0131na girer.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Deneyim_Paylasimlari_ve_Tesvik_Edicilik_Degerlendirmesi\"><\/span>Deneyim Payla\u015f\u0131mlar\u0131 ve Te\u015fvik Edicilik De\u011ferlendirmesi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>\u00d6zellikle, bu te\u015fvik edicilik uygunluk de\u011ferlendirmesinin zor oldu\u011fu durum, deneyim payla\u015f\u0131mlar\u0131d\u0131r.<\/p>\n\n\n\n<p>Bu konuda, Heisei 30 y\u0131l\u0131 A\u011fustos ay\u0131nda (2018) yay\u0131nlanan &#8216;T\u0131bbi Reklam K\u0131lavuzu ile ilgili S&amp;S&#8217; belgesinde,<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>&#8220;T\u0131bbi kurulu\u015flar\u0131n deneyim payla\u015f\u0131mlar\u0131nda te\u015fvik edicilik varsa, reklam d\u00fczenlemelerine tabi olur&#8221;<\/p>\n<cite><a href=\"https:\/\/www.mhlw.go.jp\/content\/000371812.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">\u3010PDF\u3011Heisei 30 y\u0131l\u0131 A\u011fustos ay\u0131nda (2018) yay\u0131nlanan &#8216;T\u0131bbi Reklam K\u0131lavuzu ile ilgili S&amp;S'[ja]<\/a><\/cite><\/blockquote>\n\n\n\n<p>gibi temel bir yakla\u015f\u0131m alt\u0131nda, a\u015fa\u011f\u0131daki \u00f6rnekler verilmi\u015ftir.<\/p>\n\n\n\n<ul>\n<li>T\u0131bbi kurulu\u015fun hastalardan veya ailelerinden (\u00fccretli veya \u00fccretsiz) olumlu deneyim payla\u015f\u0131mlar\u0131 talep etmesi durumu \u2192 Te\u015fvik edicilik vard\u0131r<\/li>\n\n\n\n<li>Hastalar\u0131n veya ailelerinin, t\u0131bbi kurulu\u015fun etkisi olmadan yapt\u0131\u011f\u0131 \u00f6neriler durumu \u2192 Te\u015fvik edicilik yoktur<\/li>\n<\/ul>\n\n\n\n<p>Sonuncusu hakk\u0131nda, hastalar\u0131n (veya ailelerinin) kendi i\u015fletti\u011fi web sitesi veya SNS, s\u00f6zde hastane yorum siteleri vb. yerlere yorum g\u00f6nderme durumlar\u0131, buna girer. Ancak, \u00f6zellikle hastane yorum siteleri vb. durumlar\u0131nda,<\/p>\n\n\n\n<ul>\n<li>Web sitesinin i\u015fletmecisi, deneyim payla\u015f\u0131mlar\u0131n\u0131n i\u00e7eri\u011fini d\u00fczenler, olumsuz deneyim payla\u015f\u0131mlar\u0131n\u0131 siler veya olumlu deneyim payla\u015f\u0131mlar\u0131n\u0131 \u00fcstte g\u00f6sterir gibi deneyim payla\u015f\u0131mlar\u0131n\u0131 t\u0131bbi kurulu\u015fun lehine d\u00fczenler &amp; bu, t\u0131bbi kurulu\u015fun talebi \u00fczerine yap\u0131l\u0131rsa \u2192 Te\u015fvik edicilik vard\u0131r<\/li>\n\n\n\n<li>T\u0131bbi kurulu\u015fun talebi \u00fczerine yap\u0131lmam\u0131\u015f olsa bile, t\u0131bbi kurulu\u015fun bu \u015fekilde d\u00fczenlenmi\u015f web sitesinin i\u015fletme maliyetlerini kar\u015f\u0131lamas\u0131 durumu \u2192 Te\u015fvik edicilik vard\u0131r<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2021\/02\/medical-advertising-charts2.jpg\" alt=\"\" class=\"wp-image-29162\" \/><\/figure>\n\n\n\n<p>gibi \u00f6rnekler de verilmi\u015ftir.<\/p>\n\n\n\n<p>Ancak, bu t\u00fcr sitelerdeki &#8216;deneyim payla\u015f\u0131mlar\u0131&#8217;n\u0131n yasall\u0131\u011f\u0131, yukar\u0131daki &#8216;i\u015fletme maliyeti&#8217; &#8216;kar\u015f\u0131lama&#8217; gibi kavramlarla ili\u015fkili olarak, olduk\u00e7a karma\u015f\u0131kt\u0131r. A\u015fa\u011f\u0131daki makalede detayl\u0131 olarak anlat\u0131lm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p><a href=\"https:\/\/monolith.law\/corporate\/medical-institution-reward-law\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/monolith.law\/corporate\/medical-institution-reward-law[ja]<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Genel_Gorusler_Ifade_Eden_Makaleler_ve_Belirlilik_Degerlendirmesi\"><\/span>Genel G\u00f6r\u00fc\u015fler \u0130fade Eden Makaleler ve Belirlilik De\u011ferlendirmesi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Ayr\u0131ca, belirlilik konusunda,<\/p>\n\n\n\n<ul>\n<li>&#8220;Bu bir reklam de\u011fildir.&#8221; ifadesi olmas\u0131na ra\u011fmen, hastane ad\u0131 vb. bilgilerin belirtilmesi durumu<\/li>\n\n\n\n<li>Tedavi y\u00f6ntemlerini tan\u0131tan kitaplar, bro\u015f\u00fcrler ve web siteleri \u015feklinde olmas\u0131na ra\u011fmen, belirli (birden fazla durum da dahil) hastane adlar\u0131n\u0131n, telefon numaralar\u0131n\u0131n veya web sitesi adreslerinin belirtilmesi durumu, b\u00f6ylece genel halk\u0131n ilgili hastaneyi kolayca belirleyebilmesi<\/li>\n<\/ul>\n\n\n\n<p>durumlar\u0131nda da, belirlilik reddedilmez.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Tibbi_Hukukun_Uygulanmadigi_Durumlar_Ornek_1\"><\/span>T\u0131bbi Hukukun Uygulanmad\u0131\u011f\u0131 Durumlar (\u00d6rnek 1)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>E\u011fer bir durum t\u0131bbi reklamc\u0131l\u0131k kapsam\u0131na girmiyorsa, Japon T\u0131bbi Hukuk ve T\u0131bbi Reklamc\u0131l\u0131k K\u0131lavuzu&#8217;nun uygulanmas\u0131 s\u00f6z konusu olmaz. Dolay\u0131s\u0131yla, T\u0131bbi Hukuk&#8217;a dayal\u0131 herhangi bir d\u00fczenleme olmaz ve prensip olarak her t\u00fcrl\u00fc makaleyi yay\u0131nlama \u00f6zg\u00fcrl\u00fc\u011f\u00fcne sahip olursunuz.<\/p>\n\n\n\n<p>Ancak, geni\u015f anlamda t\u0131bbi konularla ilgili yasal d\u00fczenlemeler aras\u0131nda a\u015fa\u011f\u0131dakiler de bulunmaktad\u0131r:<\/p>\n\n\n\n<ul>\n<li>\u0130la\u00e7 ve t\u0131bbi cihazlar\u0131n adlar\u0131, etkinlik ve etkileri, performanslar\u0131 vb. hakk\u0131nda yan\u0131lt\u0131c\u0131 ve abart\u0131l\u0131 reklamlar\u0131n yasaklanmas\u0131 (Japon \u0130la\u00e7 ve T\u0131bbi Cihazlar Yasas\u0131&#8217;n\u0131n 66. maddesi 1. f\u0131kras\u0131)<\/li>\n\n\n\n<li>Onay al\u0131nmam\u0131\u015f ila\u00e7 ve t\u0131bbi cihazlar\u0131n adlar\u0131, etkinlik ve etkileri, performanslar\u0131 vb. hakk\u0131nda reklam yapman\u0131n yasaklanmas\u0131 (ayn\u0131 yasan\u0131n 68. maddesi)<\/li>\n\n\n\n<li>G\u0131da olarak sat\u0131lan \u00fcr\u00fcnlerin sa\u011fl\u0131k art\u0131r\u0131c\u0131 etkileri hakk\u0131nda yan\u0131lt\u0131c\u0131 ve yan\u0131lg\u0131ya yol a\u00e7an reklamlar\u0131n yasaklanmas\u0131 (Japon Sa\u011fl\u0131k Art\u0131rma Yasas\u0131&#8217;n\u0131n 31. maddesi 1. f\u0131kras\u0131)<\/li>\n\n\n\n<li>Rakip i\u015fletmelerden ger\u00e7e\u011fe ayk\u0131r\u0131 olarak daha \u00fcst\u00fcn oldu\u011funu belirten ifadelerin yasaklanmas\u0131 (Japon Hediye G\u00f6sterme Yasas\u0131&#8217;n\u0131n 5. maddesi 1. f\u0131kras\u0131)<\/li>\n\n\n\n<li>Yan\u0131lg\u0131ya yol a\u00e7an ve yan\u0131lt\u0131c\u0131 reklamlar\u0131n yasaklanmas\u0131 (Japon Haks\u0131z Rekabetin \u00d6nlenmesi Yasas\u0131&#8217;n\u0131n 21. maddesi 2. f\u0131kras\u0131)<\/li>\n<\/ul>\n\n\n\n<p>Bu t\u00fcr reklamlar, &#8220;T\u0131bbi Hukuk ve T\u0131bbi Reklamc\u0131l\u0131k K\u0131lavuzu&#8217;nun uygulanmad\u0131\u011f\u0131&#8221; durumlarda bile sorun olabilece\u011fi i\u00e7in dikkatli olunmal\u0131d\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dal_2_Yasaklarin_Uygulanabilirligi\"><\/span>Dal 2: Yasaklar\u0131n Uygulanabilirli\u011fi<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2021\/02\/medical-advertising-charts1.jpg\" alt=\"\" class=\"wp-image-29160\" \/><\/figure>\n\n\n\n<p>T\u0131bbi reklamlar\u0131n kapsam\u0131na giren durumlarda, a\u015fa\u011f\u0131daki ifadeler &#8220;yasaklanm\u0131\u015f eylemler&#8221; olarak kabul edilir ve yasad\u0131\u015f\u0131d\u0131r (Japon Yasas\u0131 6. Madde 5. F\u0131kra 1 ve 2, Kural 1. Madde 9)<\/p>\n\n\n\n<p>(\u2170) Yan\u0131lt\u0131c\u0131 reklamlar<br>(\u2171) Kar\u015f\u0131la\u015ft\u0131rmal\u0131 \u00fcst\u00fcn reklamlar<br>(\u2172) Abart\u0131l\u0131 reklamlar<br>(\u2173) Kamu d\u00fczenine ve ahlaka ayk\u0131r\u0131 i\u00e7erikli reklamlar<br>(\u2174) Hastalar\u0131n veya di\u011fer ki\u015filerin subjektif g\u00f6r\u00fc\u015fleri veya duyumlar\u0131na dayal\u0131, tedavi veya etkileri hakk\u0131nda deneyimlerin reklam\u0131<br>(\u2175) Tedavi veya etkileri hakk\u0131nda, hastalar\u0131n veya di\u011fer ki\u015filerin yan\u0131lg\u0131ya d\u00fc\u015fme riski olan tedavi \u00f6ncesi veya sonras\u0131 foto\u011fraflar\u0131n reklam\u0131<\/p>\n\n\n\n<p>Bunlar &#8220;yasaklanm\u0131\u015f eylemler&#8221; ad\u0131 verilen kategoride yer al\u0131r ve &#8220;t\u0131bbi reklamlar\u0131n kapsam\u0131na girdi\u011fi durumlarda, kesinlikle belirtilmemesi gereken konular&#8221; anlam\u0131na gelir.<\/p>\n\n\n\n<p>Yasaklanm\u0131\u015f eylemlerle ilgili sorunlar\u0131n \u00e7o\u011funlukla ortaya \u00e7\u0131kt\u0131\u011f\u0131 durumlar, &#8220;tedavi \u00f6ncesi veya sonras\u0131 foto\u011fraflar&#8221; yani genellikle before\/after g\u00f6r\u00fcnt\u00fclerinin yay\u0131nlan\u0131p yay\u0131nlanmayaca\u011f\u0131d\u0131r. Bu t\u00fcr g\u00f6r\u00fcnt\u00fcler \u00f6zellikle kozmetik t\u0131p alan\u0131nda s\u0131k\u00e7a kullan\u0131l\u0131r, ancak &#8220;hastalar\u0131n veya di\u011fer ki\u015filerin yan\u0131lg\u0131ya d\u00fc\u015fme riski&#8221; kriteri hukuki a\u00e7\u0131dan zor bir de\u011ferlendirme gerektirir. Bu konuda a\u015fa\u011f\u0131daki makalede daha ayr\u0131nt\u0131l\u0131 bilgi verilmi\u015ftir.<\/p>\n\n\n\n<p><a href=\"https:\/\/monolith.law\/corporate\/cosmetic-surgery-image-point\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/monolith.law\/corporate\/cosmetic-surgery-image-point[ja]<\/a><\/p>\n\n\n\n<p>Ve e\u011fer bu yasaklara ayk\u0131r\u0131 davran\u0131l\u0131rsa,<\/p>\n\n\n\n<ul>\n<li>Reklam\u0131n durdurulmas\u0131 veya i\u00e7eri\u011fin d\u00fczeltilmesi i\u00e7in idari y\u00f6nlendirme<\/li>\n\n\n\n<li>Raporlama emri veya yerinde denetim (Japon Yasas\u0131 6. Madde 8. F\u0131kra 1)<\/li>\n\n\n\n<li>Durdurma emri veya d\u00fczeltme emri (Japon Yasas\u0131 6. Madde 8. F\u0131kra 2)<\/li>\n\n\n\n<li>Ceza davas\u0131<\/li>\n\n\n\n<li>Hapis veya para cezas\u0131 (Japon Yasas\u0131 87. Madde 1. F\u0131kra, 89. Madde 2. F\u0131kra)<\/li>\n\n\n\n<li>Y\u00f6netici de\u011fi\u015fikli\u011fi emri (Japon Yasas\u0131 28. Madde)<\/li>\n\n\n\n<li>Hastane veya klinik a\u00e7ma izninin iptali veya kapat\u0131lmas\u0131 (Japon Yasas\u0131 29. Madde 1. F\u0131kra 4)<\/li>\n\n\n\n<li>Yay\u0131n<\/li>\n<\/ul>\n\n\n\n<p>gibi cezalar\u0131 kabul etmek zorunda kalabilirsiniz.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dal_3_Sinirli_Kaldirma_Kosullarinin_Uygunlugu\"><\/span>Dal 3: S\u0131n\u0131rl\u0131 Kald\u0131rma Ko\u015fullar\u0131n\u0131n Uygunlu\u011fu<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Yasaklanan durumlara uymad\u0131ysan\u0131z, bir sonraki soru &#8220;S\u0131n\u0131rl\u0131 Kald\u0131rma Ko\u015fullar\u0131&#8221;n\u0131n uygunlu\u011fudur.<\/p>\n\n\n\n<p>Bu &#8220;S\u0131n\u0131rl\u0131 Kald\u0131rma Ko\u015fullar\u0131&#8221; biraz karma\u015f\u0131k bir kavram olabilir, ancak hastane veya klinikler hakk\u0131ndaki makaleleri ve g\u00f6nderileri yay\u0131nlarken, bu ko\u015fullar\u0131 kar\u015f\u0131lamak her zaman gerekli de\u011fildir. Ancak a\u015fa\u011f\u0131da belirtildi\u011fi gibi<\/p>\n\n\n\n<ul>\n<li>S\u0131n\u0131rl\u0131 Kald\u0131rma Ko\u015fullar\u0131n\u0131 kar\u015f\u0131lad\u0131\u011f\u0131nda \u2192 T\u0131bbi reklamlara uymayan durumlarla ayn\u0131 \u015fekilde, prensip olarak her \u015feyi belirtme olana\u011f\u0131na sahipsiniz<\/li>\n\n\n\n<li>S\u0131n\u0131rl\u0131 Kald\u0131rma Ko\u015fullar\u0131n\u0131 kar\u015f\u0131lamad\u0131\u011f\u0131nda \u2192 A\u015fa\u011f\u0131da belirtildi\u011fi gibi sadece &#8220;Reklam Yap\u0131labilir Hususlar&#8221;\u0131 belirtme olana\u011f\u0131na sahipsiniz<\/li>\n<\/ul>\n\n\n\n<p>durumlar\u0131 s\u00f6z konusudur. Ve S\u0131n\u0131rl\u0131 Kald\u0131rma Ko\u015fullar\u0131 a\u015fa\u011f\u0131daki gibidir:<\/p>\n\n\n\n<ol>\n<li>Web sitesi veya benzeri reklamlarda, hastalar\u0131n kendi talepleri \u00fczerine elde edebilecekleri, t\u0131bbi se\u00e7imler i\u00e7in uygun bilgileri g\u00f6stermek<\/li>\n\n\n\n<li>Hastalar\u0131n kolayca sorgulayabilece\u011fi bilgi i\u00e7eri\u011fi hakk\u0131nda, sorgulama adresini belirtmek veya di\u011fer y\u00f6ntemlerle a\u00e7\u0131k\u00e7a belirtmek<\/li>\n\n\n\n<li>\u00d6zg\u00fcr muayene ile ilgili olarak genellikle gerekli olan tedavi i\u00e7eri\u011fi, maliyetler vb. hakk\u0131nda bilgi sa\u011flamak<\/li>\n\n\n\n<li>\u00d6zg\u00fcr muayene ile ilgili tedavilerin ana riskleri, yan etkileri vb. hakk\u0131nda bilgi sa\u011flamak<\/li>\n<\/ol>\n\n\n\n<p>3. ve 4. maddeler, sadece \u00f6zg\u00fcr muayene durumunda gereklidir, sigortal\u0131 muayene durumunda sadece 1. ve 2. maddeler yeterlidir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sinirlamanin_Kaldirilma_Sartlarini_Karsiladigi_Durumlar_Model_2\"><\/span>S\u0131n\u0131rlaman\u0131n Kald\u0131r\u0131lma \u015eartlar\u0131n\u0131 Kar\u015f\u0131lad\u0131\u011f\u0131 Durumlar (Model 2)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Bu durumda, yukar\u0131da belirtildi\u011fi gibi yasaklanan maddelerin belirtilmesinin m\u00fcmk\u00fcn olmad\u0131\u011f\u0131 varsay\u0131l\u0131r. Ancak, di\u011fer y\u00f6nlerden bak\u0131ld\u0131\u011f\u0131nda, Model 1 ile ayn\u0131 \u015fekilde, prensip olarak her t\u00fcrl\u00fc makaleyi yay\u0131mlayabiliriz. Ancak, di\u011fer yasalar\u0131n uygulanmayaca\u011f\u0131 anlam\u0131na gelmez. Bu nedenle,<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>\u0130la\u00e7 ve t\u0131bbi cihazlar\u0131n adlar\u0131, etkinlik ve etkileri, performanslar\u0131 vb. hakk\u0131nda yan\u0131lt\u0131c\u0131 ve abart\u0131l\u0131 reklamlar\u0131n yasaklanmas\u0131 (Japon \u0130la\u00e7 ve T\u0131bbi Cihazlar Yasas\u0131 66. Madde 1. F\u0131kra)<br>Onay al\u0131nmam\u0131\u015f ila\u00e7 ve t\u0131bbi cihazlar\u0131n adlar\u0131, etkinlik ve etkileri, performanslar\u0131 vb. hakk\u0131nda reklamlar\u0131n yasaklanmas\u0131 (ayn\u0131 yasa 68. Madde)<br>G\u0131da olarak sat\u0131lan \u00fcr\u00fcnlerin sa\u011fl\u0131k art\u0131r\u0131c\u0131 etkileri hakk\u0131nda yan\u0131lt\u0131c\u0131 ve yan\u0131lg\u0131ya yol a\u00e7an reklamlar\u0131n yasaklanmas\u0131 (Japon Sa\u011fl\u0131k Art\u0131rma Yasas\u0131 31. Madde 1. F\u0131kra)<br>Rakip i\u015fletmelerden daha \u00fcst\u00fcn oldu\u011funu ger\u00e7e\u011fe ayk\u0131r\u0131 bir \u015fekilde belirtmenin yasaklanmas\u0131 (Japon Hediyeli Reklam Yasas\u0131 5. Madde 1. F\u0131kra)<br>Yan\u0131lg\u0131ya yol a\u00e7an reklamlar, yan\u0131lt\u0131c\u0131 reklamlar\u0131n yasaklanmas\u0131 (Japon Haks\u0131z Rekabetin \u00d6nlenmesi Yasas\u0131 21. Madde 2. F\u0131kra)<\/p>\n<\/blockquote>\n\n\n\n<p>Bu d\u00fczenlemelere dikkat etmemiz gerekti\u011fi anlam\u0131na gelir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sinirlamanin_Kaldirilma_Sartlarini_Karsilamama_Durumu_Ornek_3\"><\/span>S\u0131n\u0131rlaman\u0131n Kald\u0131r\u0131lma \u015eartlar\u0131n\u0131 Kar\u015f\u0131lamama Durumu (\u00d6rnek 3)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Bu durumda, sadece reklam yap\u0131labilir konular belirtilebilir.<\/p>\n\n\n\n<p>Ve reklam yap\u0131labilir konular, Japon Sa\u011fl\u0131k Hukuku&#8217;nun 6.5 maddesinin 3. f\u0131kras\u0131nda belirtildi\u011fi \u00fczere, a\u015fa\u011f\u0131daki gibidir.<\/p>\n\n\n\n<p>K\u0131sacas\u0131, &#8220;Yasa, bu t\u00fcr bilgilerin belirtilmesinin sorun olmayaca\u011f\u0131n\u0131 belirtir, ger\u00e7ekte m\u00fc\u015fteri \u00e7ekme etkisi gibi bir \u015fey beklenmeyen sadece bilgiler belirtilebilir&#8221; \u015feklinde bir durumdur.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote\">\n<p>1. Doktor veya di\u015f hekimi oldu\u011funu belirtme<br>2. Klinik ad\u0131<br>3. \u0130lgili hastane veya klini\u011fin ad\u0131, telefon numaras\u0131 ve konumu ve ilgili hastane veya klini\u011fin y\u00f6neticisinin ad\u0131<br>4. Muayene g\u00fcn\u00fc veya muayene saatleri veya randevu ile muayene yap\u0131l\u0131p yap\u0131lmad\u0131\u011f\u0131<br>5. Belirli bir t\u0131bbi hizmeti sa\u011flamak \u00fczere yasal d\u00fczenlemelere dayanarak belirlenen hastane veya klinik veya doktor veya di\u015f hekimi oldu\u011fu durumda, bu durumu belirtme<br>6. 5.2 maddenin 1. f\u0131kras\u0131nda belirtilen onay\u0131 alan doktor oldu\u011fu durumda, bu durumu belirtme<br>7. B\u00f6lgesel Sa\u011fl\u0131k \u0130\u015fbirli\u011fi Te\u015fvik Kurulu\u015fu&#8217;nun (70.5 maddenin 1. f\u0131kras\u0131nda belirtilen B\u00f6lgesel Sa\u011fl\u0131k \u0130\u015fbirli\u011fi Te\u015fvik Kurulu\u015fu&#8217;nu ifade eder. 30.4 maddenin 12. f\u0131kras\u0131nda ayn\u0131d\u0131r.) kat\u0131l\u0131mc\u0131 hastanesi oldu\u011fu durumda, bu durumu belirtme<br>8. Yat\u0131\u015f tesislerinin varl\u0131\u011f\u0131, 7. maddenin 2. f\u0131kras\u0131nda belirtilen yatak t\u00fcrlerinin say\u0131s\u0131, doktor, di\u015f hekimi, eczac\u0131, hem\u015fire ve di\u011fer \u00e7al\u0131\u015fanlar\u0131n say\u0131s\u0131 ve ilgili hastane veya klini\u011fin tesisleri, ekipmanlar\u0131 veya \u00e7al\u0131\u015fanlar\u0131 hakk\u0131nda di\u011fer konular<br>9. \u0130lgili hastane veya klinikte t\u0131bbi hizmetlerde bulunan sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n ad\u0131, ya\u015f, cinsiyet, pozisyon, \u00f6zge\u00e7mi\u015f ve di\u011fer ilgili sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 hakk\u0131nda konular, Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakan\u0131 taraf\u0131ndan belirlenen ve hastalar\u0131n uygun t\u0131bbi se\u00e7imlerine katk\u0131da bulunanlar<br>10. Hastalar veya ailelerinden gelen t\u0131bbi dan\u0131\u015fmalara yan\u0131t verme \u00f6nlemleri, t\u0131bbi g\u00fcvenli\u011fi sa\u011flama \u00f6nlemleri, ki\u015fisel bilgilerin uygun \u015fekilde i\u015flenmesini sa\u011flama \u00f6nlemleri ve di\u011fer ilgili hastane veya klini\u011fin y\u00f6netimi veya i\u015fletilmesi hakk\u0131nda konular<br>11. Ba\u015fka bir hastane veya klinik veya di\u011fer sa\u011fl\u0131k hizmetleri veya refah hizmetleri sa\u011flay\u0131c\u0131s\u0131na y\u00f6nlendirme yapabilme, bu sa\u011flay\u0131c\u0131lar ve ilgili hastane veya klinik aras\u0131ndaki tesislerin, ekipmanlar\u0131n veya aletlerin ortak kullan\u0131m\u0131 durumu ve di\u011fer ilgili hastane veya klinik ve sa\u011fl\u0131k hizmetleri veya refah hizmetleri sa\u011flay\u0131c\u0131lar\u0131 aras\u0131ndaki i\u015fbirli\u011fi hakk\u0131nda konular<br>12. T\u0131bbi kay\u0131tlar ve di\u011fer t\u0131bbi kay\u0131tlar hakk\u0131nda bilgi sa\u011flama, 6.4 maddenin 3. f\u0131kras\u0131nda belirtilen belgelerin teslimi ve di\u011fer ilgili hastane veya klini\u011fin t\u0131bbi hizmetleri hakk\u0131nda bilgi sa\u011flama hakk\u0131nda konular<br>13. \u0130lgili hastane veya klini\u011fin sa\u011flad\u0131\u011f\u0131 t\u0131bbi hizmetlerin i\u00e7eri\u011fi hakk\u0131nda konular (muayene, cerrahi ve di\u011fer tedavi y\u00f6ntemleri, hastalar\u0131n uygun t\u0131bbi se\u00e7imlerine katk\u0131da bulunanlarla s\u0131n\u0131rl\u0131d\u0131r ve Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakan\u0131 taraf\u0131ndan belirlenir.)<br>14. \u0130lgili hastane veya klini\u011fin hastalar\u0131n\u0131n ortalama yat\u0131\u015f s\u00fcresi, ortalama ayaktan veya yatan hasta say\u0131s\u0131 ve di\u011fer t\u0131bbi hizmetlerin sonu\u00e7lar\u0131 hakk\u0131nda konular, hastalar\u0131n uygun t\u0131bbi se\u00e7imlerine katk\u0131da bulunanlar ve Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakan\u0131 taraf\u0131ndan belirlenenler<br>15. Sa\u011fl\u0131k, \u00c7al\u0131\u015fma ve Refah Bakan\u0131 taraf\u0131ndan belirlenen ve \u00f6nceki maddelerle ayn\u0131 d\u00fczeyde olan di\u011fer konular<\/p>\n<cite>Japon Sa\u011fl\u0131k Hukuku&#8217;nun 6.5 maddesinin 3. f\u0131kras\u0131 <\/cite><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ozet\"><\/span>\u00d6zet<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Bu \u015fekilde, Japon Sa\u011fl\u0131k Hukuku ve Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k K\u0131lavuzu genel olarak olduk\u00e7a karma\u015f\u0131k olabilir, ancak yukar\u0131daki ak\u0131\u015f \u015femas\u0131na g\u00f6re d\u00fc\u015f\u00fcn\u00fcrseniz, belirli bir dereceye kadar anlayabilirsiniz.<\/p>\n\n\n\n<p>Bu t\u00fcr bir ak\u0131\u015f \u015femas\u0131 \u00fczerinde, ne t\u00fcr bir ifade yap\u0131laca\u011f\u0131n\u0131, kullan\u0131c\u0131lara ne t\u00fcr bir g\u00f6nderi yap\u0131laca\u011f\u0131n\u0131 ve bunun nas\u0131l kontrol edilece\u011fini d\u00fc\u015f\u00fcnmek, hastane veya klinik gibi siteler olu\u015ftururken, bu konularla ilgili yorum siteleri tasarlarken d\u00fc\u015f\u00fcnme \u015fekliniz olacakt\u0131r.<\/p>\n\n\n\n<p>Ancak, bu makalede tan\u0131tt\u0131\u011f\u0131m\u0131z \u015fey, yaln\u0131zca temel bir ak\u0131\u015f \u015femas\u0131d\u0131r ve ger\u00e7ekte, her bir b\u00f6l\u00fcm\u00fcn kararlar\u0131 ve disiplinleri olduk\u00e7a uzmanla\u015fm\u0131\u015ft\u0131r. Bu t\u00fcr reklam d\u00fczenlemelerinin sorun olabilece\u011fi web siteleri, web hizmetleri vb. olu\u015ftururken, Japon Sa\u011fl\u0131k Hukuku ve Japon Sa\u011fl\u0131k Reklamc\u0131l\u0131k K\u0131lavuzu hakk\u0131nda bilgi ve deneyime sahip bir hukuk firmas\u0131yla g\u00f6r\u00fc\u015fmek en iyisi olacakt\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hastane, klinik ve muayenehaneler gibi yerlerle ilgili reklam, bilgi sa\u011flama, kullan\u0131c\u0131 yorumlar\u0131 ve deneyim payla\u015f\u0131mlar\u0131 gibi i\u00e7eriklerin web \u00fczerinde yay\u0131nlanmas\u0131 durumunda, sorun olu\u015fturan konu, Ja [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":64257,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[30,24],"acf":[],"_links":{"self":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61075"}],"collection":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/comments?post=61075"}],"version-history":[{"count":3,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61075\/revisions"}],"predecessor-version":[{"id":64258,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/posts\/61075\/revisions\/64258"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media\/64257"}],"wp:attachment":[{"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/media?parent=61075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/categories?post=61075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/monolith.law\/tr\/wp-json\/wp\/v2\/tags?post=61075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}